Literature DB >> 5705388

The management of myelomatosis.

A F Broad, J N Godlee, E W Emery, T A Prankerd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5705388      PMCID： PMC2466494          DOI： 10.1136/pgmj.44.516.803

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  3 in total

1.  MELPHALAN THERAPY IN MYELOMATOSIS.

Authors:  J WALDENSTROEM
Journal:  Br Med J       Date:  1964-04-04

2.  Melphalan in multiple myeloma.

Authors:  B Hoogstraten; P R Sheehe; J Cuttner; T Cooper; R A Kyle; R A Oberfield; S R Townsend; J B Harley; D M Hayes; G Costa; J F Holland
Journal:  Blood       Date:  1967-07       Impact factor: 22.113

3.  Review of regional limb perfusion with melphalan for malignant melanoma.

Authors:  W T Irvine; R J Luck
Journal:  Br Med J       Date:  1966-03-26
  3 in total
  1 in total

1.  Factors influencing the prognosis in myelomatosis.

Authors:  A A Dawson; D Ogston
Journal:  Postgrad Med J       Date:  1971-10       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.